{{Rsnum
|rsid=7214479
|Chromosome=17
|position=71194808
|Orientation=plus
|GMAF=0.4063
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=CASC17
|Gene_s=CASC17
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 54.9 | 14.2
| HCB | 15.3 | 48.9 | 35.8
| JPT | 30.1 | 53.1 | 16.8
| YRI | 81.6 | 17.7 | 0.7
| ASW | 66.1 | 30.4 | 3.6
| CHB | 15.3 | 48.9 | 35.8
| CHD | 13.8 | 55.0 | 31.2
| GIH | 28.7 | 53.5 | 17.8
| LWK | 80.9 | 18.2 | 0.9
| MEX | 20.7 | 44.8 | 34.5
| MKK | 51.6 | 38.1 | 10.3
| TSI | 27.5 | 49.0 | 23.5
| HapMapRevision=28
}}

rs7214479 increases susceptibility to Prostate cancer 1.17 times for carriers of the T allele {{PMID|17603485}}

{{PMID Auto
|PMID=20690139
|Title=Meta-analysis of genome-wide and replication association studies on prostate cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}